Meanwhile, multiple variants have also entered the market, including semaglutide injection, semaglutide tablets, liraglutide, tirzepatide, dulaglutide, exenatide, and exenatide extended release
Retatrutide (also called as Retatrutide acetate, LY3437943) is a next-generation metabolic peptide distinguished by its triple-agonist mechanism targeting GLP-1, GIP, and glucagon receptors simultaneously
Get 25% off sitewide by adding this Noom code
Integrating the scoping review with insights derived from the NGT facilitates gathering real-world clinical insights
Investigations into biased agonism, where medications are designed to selectively activate beneficial GLP-1 receptor pathways while minimizing those that cause side effects, could eventually produce GLP-1 medications with significantly reduced dry mouth profiles